Date: Feb. 22-23, 2018.
See the agenda. Read the speaker bios.
Download the slides: Day 1, Day 2. Read the transcript.
Watch the videos: Session I. Session IIA. Session IIB. SessionIII. SessionIVA. Session IVB.
Some speakers have elected to have some or all of their slides withheld.
SESSION I: Preclinical Considerations
SESSION II: Clinical Considerations
SESSION III: Immunotherapy
SESSION IV: Other Targeted Therapies
is great interest among clinicians as well as regulatory authorities to
address the lack of drug development for products intended specifically
for use with radiation therapy. Emerging from the enthusiasm and
momentum of a session at the AACR-sponsored Accelerating Anticancer
Agent Development and Validation Workshop (May 3-5, 2017, Bethesda,
Maryland), this two-day workshop will bring together regulatory
agencies, industry, and academia to discuss the challenges in greater
depth and come up with a path forward.